Trial intelligence / Profile preview

Effect of Extraneal (Icodextrin) on Triglyceride Levels in PD Patients

NCT02166359Completed

Sponsor
Dong-A University
Start
Jun 2014
Primary completion
Mar 2019
Modality
Polymer-based Nanoparticles, Device-based Delivery
Countries
1
01

Overview

Randomised trial of icodextrin in end stage renal disease (ESRD) (2 arms), sponsored by Dong-A University. Primary endpoint: Mean difference and change of triglyceride levels at 3 months. Started Jun 2014; status: completed.

02

Drugs

icodextrin
03

Conditions

end stage renal disease (ESRD)

Beyond the preview

Go deeper on NCT02166359.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02166359.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call